get a key
steadybase-$ company MDXG
account_id none on file
legal_name Mimedx Group, Inc.
ticker MDXG
cik 1376339
domain mimedx.com
entry_point_account_id none on file
name MiMedx Group Inc
exchange Nasdaq
sector Health Care
hq Marietta, GA, United States
calls 1 filings 0 executives 7 family 0
why_nownone on file
calls
Sales and marketing expense was $46 million, or 72% of net sales, compared to $48 million, or 49% of net sales in the prior year period. The decrease was primarily driven by our cost reduction initiatives, which resulted in lower compensation, travel, and meeting expenses. We also incurred lower commission expenses due to lower sales.

Jul 29, 2026 / receipt, needs a key / Doug Rice, CFO | earnings call 2026-07-29 | transcript a27c8e7f-f84c-482b-8d62-66bd2b230ca7 | chars 18729-19065 | segment 19

filingsnone on file
executives
David Coles Interim Chief Executive Officer - receipt
Doug Rice CFO linkedin receipt
Joe Capper CEO - receipt
Joseph H. Capper Chief Executive Officer - receipt
Peter M. Carlson Chief Financial Officer - receipt
Ricci S. Whitlow Executive Vice President and Chief Operating Officer - receipt
William L. Phelan Senior Vice President and Chief Accounting Officer - receipt
familynone on file
upcoming
2026-11-04 earnings call scheduled ir
changes
2023-01-30 Chief Executive Officer, appointed sec_8k
2023-01-30 Interim Chief Executive Officer, departed sec_8k
2023-01-03 Executive Vice President and Chief Operating Officer, appointed sec_8k
2022-09-06 director, appointed sec_8k
2020-05-05 Senior Vice President and Chief Accounting Officer, appointed sec_8k
2020-03-19 Chief Financial Officer, appointed sec_8k
2018-07-11 Interim Chief Executive Officer, appointed sec_8k
2018-07-02 Interim Chief Executive Officer, appointed sec_8k
mcp_package_hint
steadybase-$